Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced additional positive data from its Phase 2...
BioVaxys Technology Corp. is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is...
NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, announced it has received approval from the Italian Medicines Agency (AIFA) to commence...
Ardelyx, Inc. , a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs,...
